WallStreetZenWallStreetZen

NASDAQ: NXL
Nexalin Technology Inc Stock

$2.31+0.67 (+40.85%)
Updated Jun 24, 2024
NXL Price
$2.31
Fair Value Price
N/A
Market Cap
$17.18M
52 Week Low
$0.25
52 Week High
$3.40
P/E
-3.5x
P/B
7.38x
P/S
65.54x
PEG
N/A
Dividend Yield
N/A
Revenue
$158.86k
Earnings
-$4.94M
Gross Margin
82.5%
Operating Margin
-3,091.88%
Profit Margin
-3,110.6%
Debt to Equity
0.22
Operating Cash Flow
-$3M
Beta
0.62
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NXL Overview

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NXL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NXL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NXL is poor value based on its book value relative to its share price (7.38x), compared to the US Medical Devices industry average (3.87x)
P/B vs Industry Valuation
NXL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NXL due diligence checks available for Premium users.

Be the first to know about important NXL news, forecast changes, insider trades & much more!

NXL News

Valuation

NXL fair value

Fair Value of NXL stock based on Discounted Cash Flow (DCF)
Price
$2.31
Fair Value
$0.02
Overvalued by
9,861.56%
NXL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NXL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.5x
Industry
30.8x
Market
30.03x

NXL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
7.38x
Industry
3.87x
NXL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NXL's financial health

Profit margin

Revenue
$78.7k
Net Income
-$1.0M
Profit Margin
-1,323.4%
NXL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NXL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.8M
Liabilities
$507.2k
Debt to equity
0.22
NXL's short-term assets ($2.56M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NXL's short-term assets ($2.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NXL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$763.3k
Investing
$729.3k
Financing
$0.0
NXL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NXL vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NXL$17.18M+40.85%-3.50x7.38x
QTI$16.08M+1.76%-2.78x-3.27x
AMIX$19.60M-0.95%-0.99x2.57x
NUVO$19.97M+4.86%-0.81x-0.30x
IINN$21.21M+1.12%-1.46x3.70x

Nexalin Technology Stock FAQ

What is Nexalin Technology's quote symbol?

(NASDAQ: NXL) Nexalin Technology trades on the NASDAQ under the ticker symbol NXL. Nexalin Technology stock quotes can also be displayed as NASDAQ: NXL.

If you're new to stock investing, here's how to buy Nexalin Technology stock.

What is the 52 week high and low for Nexalin Technology (NASDAQ: NXL)?

(NASDAQ: NXL) Nexalin Technology's 52-week high was $3.40, and its 52-week low was $0.25. It is currently -32.06% from its 52-week high and 813.04% from its 52-week low.

How much is Nexalin Technology stock worth today?

(NASDAQ: NXL) Nexalin Technology currently has 7,436,562 outstanding shares. With Nexalin Technology stock trading at $2.31 per share, the total value of Nexalin Technology stock (market capitalization) is $17.18M.

Nexalin Technology stock was originally listed at a price of $2.25 in Sep 16, 2022. If you had invested in Nexalin Technology stock at $2.25, your return over the last 1 years would have been 2.67%, for an annualized return of 2.67% (not including any dividends or dividend reinvestments).

How much is Nexalin Technology's stock price per share?

(NASDAQ: NXL) Nexalin Technology stock price per share is $2.31 today (as of Jun 24, 2024).

What is Nexalin Technology's Market Cap?

(NASDAQ: NXL) Nexalin Technology's market cap is $17.18M, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nexalin Technology's market cap is calculated by multiplying NXL's current stock price of $2.31 by NXL's total outstanding shares of 7,436,562.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.